Merger activity increased with five new deals announced and five deals closing.
- The acquisition of Audentes Therapeutics (BOLD) by Astellas Pharma (ALPMF) for $2.65 billion or $60.00 per share in cash.
- The acquisition of AK Steel Holding Corporation (AKS) by Cleveland-Cliffs (CLF) for $3 billion in an all-stock deal. Under the terms of the merger agreement, AK Steel shareholders will receive 0.40 shares of Cliffs common stock for each outstanding share of AK Steel common stock they own.
- The acquisition of Instructure (INST) by Thoma Bravo for $1.86 billion or $47.60